AMI Asset Management
NUVB icon

AMI Asset Management’s Nuvation Bio NUVB Stock Holding History

AMI Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1M Sell
179,294
-3,957
-2% -$24.8K 0.06% 54
2026
Q2 		$1.04M Sell
183,251
-9,176
-5% -$44.8K 0.06% 53
2026
Q1 		$826K Buy
192,427
+65,955
+52% +$367K 0.05% 64
2025
Q4 		$1.13M Buy
+126,472
New +$783K 0.06% 55

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Decheng Capital
Decheng Capital Menlo Park, California $685M AUM 129.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
JHC
Jones Hill Capital New York $589M AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

AMI Asset Management's NUVB Position: Q3 2026 in Review

AMI Asset Management reduced its Nuvation Bio (NUVB) stake by 2.2% in Q3 2026, selling an estimated $24.8K and leaving 179,294 shares worth $1M. The position accounts for 0.06% of the portfolio, ranked #54.

AMI Asset Management first reported a position in NUVB in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.13M in Q4 2025. 186 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • AMI Asset Management held 179,294 shares of Nuvation Bio worth $1M as of Q3 2026.
  • AMI Asset Management sold 3,957 Nuvation Bio shares in Q3 2026, an estimated $24.8K.
  • Nuvation Bio made up 0.06% of AMI Asset Management's portfolio in Q3 2026, its #54 holding.
  • AMI Asset Management first reported a position in Nuvation Bio in Q4 2025 and has held it in 4 quarters since.
  • AMI Asset Management's Nuvation Bio position peaked at $1.13M in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on AMI Asset Management's 13F filing for Q3 2026, filed 20 Oct 2026.